Status:

RECRUITING

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

Lead Sponsor:

Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions:

Cachexia

Digestive System Cancer

Eligibility:

All Genders

18+ years

Brief Summary

This study is a prospective, observational clinical study aimed at evaluating the efficacy of Megestrol Acetate for cachexia in patients with advanced digestive system tumors receiving TKI-based thera...

Eligibility Criteria

Inclusion

  • Voluntarily sign a written informed consent (ICF).
  • Age ≥ 18 years at enrollment.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.
  • Life expectancy ≥ 3 months.
  • Histologically or cytologically confirmed locally advanced or metastatic digestive system tumors that are not amenable to curative treatment, according to the 8th edition TNM staging classification.
  • Not benefiting from local anticancer therapies such as surgery, local ablation, or chemoembolization, and planned to receive TKI-based anticancer treatment, which may be combined with chemotherapy or immunotherapy).
  • Meet the diagnostic criteria for pre-cachexia or cachexia (based on Fearon diagnostic criteria).
  • Good organ function determined

Exclusion

  • Gastrointestinal obstruction.
  • Anorexia due to difficulty in eating caused by neurosis, mental illness, or pain.
  • Comorbidities such as severe cerebrovascular, cardiac, renal, or liver diseases.
  • Major surgery or trauma within the last month.
  • Allergy to any component of the investigational drug.
  • Other conditions deemed unsuitable by the investigator.

Key Trial Info

Start Date :

March 12 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06940102

Start Date

March 12 2025

End Date

December 1 2026

Last Update

April 23 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

General Hospital of Northern Theater Command

Shenyang, Liaoning, China, 110016

2

Liaoning Cancer Hospital

Shenyang, Liaoning, China, 110042